EMR — Emerson Electric Company
Is EMR overbought or oversold? Here is the current MarketMoodz read.
Emerson Electric Company (EMR) currently reads Neutral on the MarketMoodz overbought/oversold meter, as of August 19, 2026. The Industrials name (Specialty Industrial Machinery) last closed at $157.61. The rating moved from Overbought to Neutral on August 18, 2026.
- Public ratingNeutral (as of August 19, 2026)
- Last close$157.61
- Last changeMoved from Overbought to Neutral on August 18, 2026
- SectorIndustrials
- IndustrySpecialty Industrial Machinery
AI analysis
Emerson Electric Company (EMR) combines diversified end-market exposure with steady cash generation and a history of shareholder returns. Near-term activity appears neutral: sector flows and macro headlines were quiet over the past session, leaving company-specific execution and industrial end-market trends as the primary drivers. Structural tailwinds include automation, electrification and selective defense/industrial spending, while near-term headwinds stem from supply-chain friction, higher borrowing costs and the pace of non-residential capex. Absent new material macro or company-specific surprises, performance over the next month will likely track execution on margin programs and any incremental signs of pickup (or slowdown) in industrial equipment orders.
Key factors
- Diversified industrial portfolio spanning automation, commercial & residential, and climate technologies providing resilient revenue streams
- Stable cash flow generation and a historically consistent dividend that support shareholder returns and balance-sheet flexibility
- Exposure to industrial automation, electrification and data-center electrification themes which could drive medium-term organic growth
- Operational improvement programs and cost discipline that can enhance margins as supply-chain pressures normalize
- Relative defensive positioning within Industrials amid modest sector rotation into defensive manufacturing and defense procurement strength
- Reasonable valuation versus peers given steady cash flows, offering upside if market re-rates on execution or stronger end-market activity
Risks
- Slower-than-expected industrial capex and non-residential project starts due to higher borrowing costs and weaker end-market demand
- Ongoing supply-chain disruption or higher input costs that compress near-term margins and delay delivery schedules
- Execution risk on margin improvement programs and integration risks from acquisitions or portfolio reallocations
- Foreign exchange volatility and exposure to global manufacturing cycles that can depress revenue growth
- Competition from large diversified industrial peers and niche automation suppliers that could pressure pricing and share gains
- Limited short-term catalysts in the immediate four-week window and potential for broader market downside if macro news turns negative
Latest MarketMoodz coverage
See today's live rating, score and targets
Members see the live hourly rating for EMR — the numeric AI score plus targets and entry zones — while this public page updates nightly.
Start the 14-day trialThis page is for informational purposes only and is not investment, financial, tax, or legal advice. Ratings and research outputs can be wrong, incomplete, or stale. Past performance does not guarantee future results. Always do your own research and consider consulting a qualified professional.
MarketMoodz